Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2010-01-22
- Last Posted Date
- 2021-10-13
- Target Recruit Count
- 27
- Registration Number
- NCT01054144
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas
- First Posted Date
- 2010-01-14
- Last Posted Date
- 2013-12-16
- Target Recruit Count
- 2
- Registration Number
- NCT01048723
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer
- Conditions
- Recurrent Breast CancerStage IV Breast CancerMale Breast CancerUnspecified Adult Solid Tumor, Protocol Specific
- Interventions
- Biological: adenovirus-p53 transduced dendritic cell (DC) vaccineOther: Laboratory biomarker analysis
- First Posted Date
- 2010-01-05
- Last Posted Date
- 2018-04-11
- Target Recruit Count
- 44
- Registration Number
- NCT01042535
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, Effectiveness
- Conditions
- Prostate Cancer
- Interventions
- Drug: Purified isoflavones
- First Posted Date
- 2009-12-21
- Last Posted Date
- 2019-08-06
- Target Recruit Count
- 71
- Registration Number
- NCT01036321
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
🇺🇸University of Florida & Shands Medical Center - Jacksonville, Jacksonville, Florida, United States
🇺🇸James A. Haley VA Hospital, Tampa, Florida, United States
Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100
- First Posted Date
- 2009-11-05
- Last Posted Date
- 2015-09-24
- Target Recruit Count
- 22
- Registration Number
- NCT01008527
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma
- Conditions
- Metastatic Melanoma
- Interventions
- Procedure: SurgeryDrug: Administration of LymphodepletionOther: Adoptive Cell Transfer
- First Posted Date
- 2009-11-01
- Last Posted Date
- 2025-05-22
- Target Recruit Count
- 19
- Registration Number
- NCT01005745
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia
- Conditions
- Pancreatic Neoplasms
- Interventions
- Drug: Vitamin E δ-Tocotrienol
- First Posted Date
- 2009-09-28
- Last Posted Date
- 2016-03-01
- Target Recruit Count
- 26
- Registration Number
- NCT00985777
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Erlotinib Study for Myelodysplastic Syndrome (MDS)
- First Posted Date
- 2009-09-15
- Last Posted Date
- 2013-09-16
- Target Recruit Count
- 39
- Registration Number
- NCT00977548
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
Depocyt® With Sorafenib in Neoplastic Meningitis
- First Posted Date
- 2009-08-25
- Last Posted Date
- 2013-09-09
- Target Recruit Count
- 2
- Registration Number
- NCT00964743
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML)
- First Posted Date
- 2009-08-10
- Last Posted Date
- 2014-06-27
- Target Recruit Count
- 38
- Registration Number
- NCT00955916
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States